- Home
- EVAX vs FLGC Comparison
EVAX vs FLGC Comparison
Compare EVAX & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- FLGC
- Stock Information
- Founded
- EVAX 2008
- FLGC 2019
- Country
- EVAX Denmark
- FLGC United States
- Employees
- EVAX N/A
- FLGC N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- FLGC Biotechnology: Pharmaceutical Preparations
- Sector
- EVAX Health Care
- FLGC Health Care
- Exchange
- EVAX Nasdaq
- FLGC Nasdaq
- Market Cap
- EVAX 15.1M
- FLGC 15.9M
- IPO Year
- EVAX 2021
- FLGC 2021
- Fundamental
- Price
- EVAX $3.24
- FLGC $21.22
- Analyst Decision
- EVAX Strong Buy
- FLGC Strong Buy
- Analyst Count
- EVAX 2
- FLGC 1
- Target Price
- EVAX $10.00
- FLGC $156.00
- AVG Volume (30 Days)
- EVAX 95.0K
- FLGC 17.9K
- Earning Date
- EVAX 08-14-2025
- FLGC 08-01-2025
- Dividend Yield
- EVAX N/A
- FLGC N/A
- EPS Growth
- EVAX N/A
- FLGC N/A
- EPS
- EVAX N/A
- FLGC N/A
- Revenue
- EVAX $3,176,000.00
- FLGC $52,373,000.00
- Revenue This Year
- EVAX N/A
- FLGC N/A
- Revenue Next Year
- EVAX N/A
- FLGC N/A
- P/E Ratio
- EVAX N/A
- FLGC N/A
- Revenue Growth
- EVAX 1042.45
- FLGC N/A
- 52 Week Low
- EVAX $1.20
- FLGC $15.15
- 52 Week High
- EVAX $17.75
- FLGC $82.29
- Technical
- Relative Strength Index (RSI)
- EVAX 62.32
- FLGC 48.40
- Support Level
- EVAX $2.91
- FLGC $19.51
- Resistance Level
- EVAX $3.40
- FLGC $24.86
- Average True Range (ATR)
- EVAX 0.22
- FLGC 2.91
- MACD
- EVAX 0.02
- FLGC 0.15
- Stochastic Oscillator
- EVAX 79.11
- FLGC 58.54
About EVAX Evaxion Biotech
Evaxion AS is in the field of oncology. It used the AI-Immunology platform.
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.